NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance 英文参考文献.docVIP

NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance 英文参考文献.doc

  1. 1、本文档被系统程序自动判定探测到侵权嫌疑,本站暂时做下架处理。
  2. 2、如果您确认为侵权,可联系本站左侧在线QQ客服请求删除。我们会保证在24小时内做出处理,应急电话:400-050-0827。
  3. 3、此文档由网友上传,因疑似侵权的原因,本站不提供该文档下载,只提供部分内容试读。如果您是出版社/作者,看到后可认领文档,您也可以联系本站进行批量认领。
查看更多
NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance 英文参考文献

NSC23925,IdentifiedinaHigh-ThroughputCell-Based Screen,ReversesMultidrugResistance ZhenfengDuan*,EdwinChoy,FrancisJ.Hornicek SarcomaBiologyLaboratory,CenterforSarcomaandConnectiveTissueOncology,MassachusettsGeneralHospital,Boston,Massachusetts,UnitedStatesofAmerica Abstract Background: Multidrug resistance (MDR) is amajor factor which contributes tothe failure of cancer chemotherapy, and numerouseffortshavebeenattemptedtoovercomeMDR.Todate,noneoftheseattemptshaveyieldedatolerableand effectivetherapytoreverseMDR;thus,identificationofnewagentswouldbeusefulbothclinicallyandscientifically. Methodology/PrincipalFindings:Toidentifysmallmoleculecompoundsthatcanreversechemoresistance,wedeveloped a96-wellplatehigh-throughputcell-basedscreeningassayinapaclitaxelresistantovariancancercellline.Coincubating cellswithasublethalconcentrationofpaclitaxelincombinationwitheachof2,000smallmoleculecompoundsfromthe NationalCancerInstituteDiversitySetLibrary,weidentifiedapreviouslyuncharacterizedmolecule,NSC23925,thatinhibits Pgp1andreversesMDR1(Pgp1)butdoesnotinhibitMRPorBCRP-mediatedMDR.ThecytotoxicactivityofNSC23925was furtherevaluatedusingapanelofcancercelllinesexpressingPgp1,MRP,andBCRP.Wefoundthatataconcentrationof .10mMNSC23925moderatelyinhibitstheproliferationofbothsensitiveandresistantcelllineswithalmostequalactivity, butitsinhibitoryeffectwasnotalteredbyco-incubationwiththePgp1inhibitor,verapamil,suggestingthatNSC23925itself isnotasubstrateofPgp1.Additionally,NSC23925increasestheintracellularaccumulationofPgp1substrates:calceinAM, Rhodamine-123, paclitaxel, mitoxantrone, and doxorubicin. Interestingly, we further observed that, although NSC23925 directly inhibits the function of Pgp1 in a dose-dependent manner without altering the total expression level of Pgp1, NSC23925actuallystimulatesATPaseactivityofPgp,aphenomenonseeninotherPgpinhibitors. Conclusions/Significance: The ability of NSC23925 to restore sensitivity to the cytotoxic effects of chemotherapy or to preventresista

您可能关注的文档

文档评论(0)

1234554321 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档